Conference
A Novel Class of Sulfonanilides Entering Clinical Trials for Targeted Treatment of Multiple Myeloma: Dual-Mechanism Compounds Inhibiting HIF1A-Signaling and Inducing Apoptosis
Authors
Hose D; Seckinger A; Goldschmidt H; Meissner T; Leber B; Neben K; Hillengass J; Bertsch U; Janssen B; Klein B
Volume
116
Pagination
pp. 1232-1232
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 19, 2010
Name of conference
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
Conference place
Orlando, FL
Conference start date
December 4, 2010
Conference end date
December 7, 2010
Conference proceedings
BLOOD
Issue
21
ISSN
0006-4971